INTEGER HOLDINGS CORPORATION Business Acquisition, Pro Forma Net Income (Loss)
INTEGER HOLDINGS CORPORATION (ITGR) reported Business Acquisition, Pro Forma Net Income (Loss) of $0 for the 3-month period ending 2024-03-29, per its 10-Q filed 2024-04-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2024-10-24
- INTEGER HOLDINGS CORPORATION business acquisition, pro forma net income (loss) for the quarter ending 2024-03-29 was $0.00.
- INTEGER HOLDINGS CORPORATION business acquisition, pro forma net income (loss) for the quarter ending 2023-12-31 was $40.23M.
- INTEGER HOLDINGS CORPORATION business acquisition, pro forma net income (loss) for the quarter ending 2023-09-29 was $27.79M.
- INTEGER HOLDINGS CORPORATION business acquisition, pro forma net income (loss) for the quarter ending 2023-06-30 was $21.34M.
- INTEGER HOLDINGS CORPORATION business acquisition, pro forma net income (loss) for fiscal 2023 was $93.15M, a 36.67% increase from fiscal 2022.
- INTEGER HOLDINGS CORPORATION business acquisition, pro forma net income (loss) for fiscal 2022 was $68.15M, a 22.06% decline from fiscal 2021.
- INTEGER HOLDINGS CORPORATION business acquisition, pro forma net income (loss) for fiscal 2021 was $87.44M.
- INTEGER HOLDINGS CORPORATION business acquisition, pro forma net income (loss) for fiscal 2016 was $2.40M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|
| 2024-03-29 | $0.00 10-Q · filed 2024-04-25 | $40.23M derived: sum of 2 quarters · filed 2024-04-25 | $68.02M derived: sum of 3 quarters · filed 2024-10-24 | $89.36M derived: sum of 4 quarters · filed 2024-10-24 | |
| 2023-12-31 | $40.23M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $68.02M derived: sum of 2 quarters · filed 2024-10-24 | $89.36M derived: sum of 3 quarters · filed 2024-10-24 | $93.15M 10-K · filed 2024-02-20 | |
| 2023-09-29 | $27.79M 10-Q · filed 2024-10-24 | $49.13M derived: sum of 2 quarters · filed 2024-10-24 | $52.91M 10-Q · filed 2024-10-24 | ||
| 2023-06-30 | $21.34M 10-Q · filed 2024-07-25 | $28.00M 10-Q · filed 2024-07-25 | |||
| 2022-12-31 | $68.15M 10-K · filed 2024-02-20 | ||||
| 2021-12-31 | $87.44M 10-K · filed 2024-02-20 | ||||
| 2016-04-01 | -$12.66M 10-Q · filed 2016-05-10 | -$6.71M derived: sum of 2 quarters · filed 2017-02-28 | -$15.93M derived: sum of 3 quarters · filed 2017-02-28 | -$11.22M derived: sum of 4 quarters · filed 2017-02-28 | |
| 2016-01-01 | $5.95M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$3.27M derived: sum of 2 quarters · filed 2017-02-28 | $1.44M derived: sum of 3 quarters · filed 2017-02-28 | $2.40M 10-K · filed 2017-02-28 | |
| 2015-10-02 | -$9.21M 10-Q · filed 2016-11-08 | -$4.51M derived: sum of 2 quarters · filed 2016-11-08 | -$3.54M 10-Q · filed 2016-11-08 | ||
| 2015-07-03 | $4.71M 10-Q · filed 2016-08-09 | $5.67M 10-Q · filed 2016-08-09 | |||
| 2015-04-03 | $966.00K 10-Q · filed 2016-05-10 | ||||
| 2015-01-02 | -$25.86M 10-K · filed 2017-02-28 | $56.45M 10-K · filed 2015-03-03 | |||
| 2014-01-03 | $11.13M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | $22.20M derived: sum of 2 quarters · filed 2016-03-01 | $31.95M derived: sum of 3 quarters · filed 2016-03-01 | $37.61M 10-K · filed 2016-03-01 | |
| 2013-09-27 | $11.07M 10-Q · filed 2013-11-05 | $20.82M derived: sum of 2 quarters · filed 2013-11-05 | $26.49M 10-Q · filed 2013-11-05 | $20.93M derived: sum of 4 quarters · filed 2015-03-03 | |
| 2013-06-28 | $9.75M 10-Q · filed 2013-08-06 | $15.41M 10-Q · filed 2013-08-06 | $9.86M derived: sum of 3 quarters · filed 2015-03-03 | $2.30M derived: sum of 4 quarters · filed 2015-03-03 | |
| 2013-03-29 | $5.66M 10-Q · filed 2013-05-07 | $107.00K derived: sum of 2 quarters · filed 2015-03-03 | -$7.45M derived: sum of 3 quarters · filed 2015-03-03 | -$3.60M derived: sum of 4 quarters · filed 2015-03-03 | |
| 2012-12-28 | -$5.56M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | -$13.12M derived: sum of 2 quarters · filed 2015-03-03 | -$9.27M derived: sum of 3 quarters · filed 2015-03-03 | -$4.97M 10-K · filed 2015-03-03 | |
| 2012-09-28 | -$7.56M 10-Q · filed 2013-11-05 | -$3.71M derived: sum of 2 quarters · filed 2013-11-05 | $583.00K 10-Q · filed 2013-11-05 | $6.17M derived: sum of 4 quarters · filed 2014-03-04 | |
| 2012-06-29 | $3.85M 10-Q · filed 2013-08-06 | $8.14M 10-Q · filed 2013-08-06 | $13.73M derived: sum of 3 quarters · filed 2014-03-04 | $20.96M derived: sum of 4 quarters · filed 2014-03-04 | |
| 2012-03-30 | $4.29M 10-Q · filed 2013-05-07 | $9.88M derived: sum of 2 quarters · filed 2014-03-04 | $17.11M derived: sum of 3 quarters · filed 2014-03-04 | $25.40M derived: sum of 4 quarters · filed 2014-03-04 | |
| 2011-12-30 | $5.59M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-04 | $12.81M derived: sum of 2 quarters · filed 2014-03-04 | $21.11M derived: sum of 3 quarters · filed 2014-03-04 | $32.31M 10-K · filed 2014-03-04 | |
| 2011-09-30 | $7.23M 10-Q · filed 2012-11-06 | $15.52M derived: sum of 2 quarters · filed 2012-11-06 | $26.72M 10-Q · filed 2012-11-06 | ||
| 2011-07-01 | $8.29M 10-Q · filed 2012-08-07 | $19.49M 10-Q · filed 2012-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |